Fiona Walter

Identifying Novel Biomarkers Ready for Evaluation in Low-Prevalence Populations for the Early Detection of Lower Gastrointestinal Cancers: A Systematic Review and Meta-Analysis

Paige Druce, Natalia Calanzani, Claudia Snudden, Kristi Milley, Rachel Boscott, Dawnya Behiyat, Javiera Martinez-Gutierrez, Smiji Saji, Jasmeen Oberoi, Garth Funston, Mike Messenger, Fiona M Walter, Jon Emery

Journal article  |  2021  |  ADVANCES IN THERAPY

INTRODUCTION: Detecting upper gastrointestinal (GI) cancers in primary care is challenging, as cancer symptoms are common, often n..

Time from presentation to pre-diagnostic chest X-ray in patients with symptomatic lung cancer: a cohort study using electronic patient records from English primary care

Kirsten D Arendse, Fiona M Walter, Mark Pilling, Yin Zhou, Willie Hamilton, Garth Funston

Journal article  |  2021  |  BRITISH JOURNAL OF GENERAL PRACTICE

BACKGROUND: National guidelines in England recommend prompt chest X-ray (within 14 days) in patients presenting in general practic..

CanRisk Tool-A Web Interface for the Prediction of Breast and Ovarian Cancer Risk and the Likelihood of Carrying Genetic Pathogenic Variants

Tim Carver, Simon Hartley, Andrew Lee, Alex P Cunningham, Stephanie Archer, Chantal Babb de Villiers, Jonathan Roberts, Rod Ruston, Fiona M Walter, Marc Tischkowitz, Douglas F Easton, Antonis C Antoniou

Journal article  |  2021  |  CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

BACKGROUND: The CanRisk Tool (https://canrisk.org) is the next-generation web interface for the latest version of the BOADICEA (Br..

Knowledge of cervical cancer risk factors and symptoms among women in a refugee settlement: a cross-sectional study in northern Uganda

Winnie Adoch, Christopher Orach Garimoi, Suzanne E Scott, Geoffrey Goddie Okeny, Jennifer Moodley, Henry Komakech, Fiona M Walter, Amos Deogratius Mwaka

Journal article  |  2020  |  CONFLICT AND HEALTH

BACKGROUND: There are limited data on awareness of cervical cancer risk factors and symptoms among refugee populations living in U..

Identifying Ovarian Cancer in Symptomatic Women: A Systematic Review of Clinical Tools

Garth Funston, Victoria Hardy, Gary Abel, Emma J Crosbie, Jon Emery, Willie Hamilton, Fiona M Walter

Journal article  |  2020  |  CANCERS

In the absence of effective ovarian cancer screening programs, most women are diagnosed following the onset of symptoms. Symptom-b..

The epidemiology of malignant melanoma, squamous cell carcinoma and basal cell carcinoma in the UK from 2004 to 2014: a population-based cohort analysis using the Clinical Practice Research Datalink

FN Mirza, S Yumeen, FM Walter

Journal article  |  2020  |  BRITISH JOURNAL OF DERMATOLOGY

Women's appraisal, interpretation and help-seeking for possible symptoms of breast and cervical cancer in South Africa: a qualitative study

Jane Harries, Suzanne E Scott, Fiona M Walter, Amos D Mwaka, Jennifer Moodley

Journal article  |  2020  |  BMC WOMENS HEALTH

BACKGROUND: In South Africa, breast cancer is the most commonly diagnosed cancer and cervical cancer the leading cause of cancer m..

Mapping awareness of breast and cervical cancer risk factors, symptoms and lay beliefs in Uganda and South Africa

J Moodley, D Constant, AD Mwaka, SE Scott, FM Walter

Journal article  |  2020  |  PLOS ONE

BACKGROUND: Breast and cervical cancer are leading causes of cancer burden in Sub-Saharan Africa (SSA). We measured breast and cer..

Faecal immunochemical test to triage patients with abdominal symptoms for suspected colorectal cancer in primary care: review of international use and guidelines

Marije van Melle, Samir IS Yep Manzano, Hugh Wilson, Willie Hamilton, Fiona M Walter, Sarah ER Bailey

Journal article  |  2020  |  FAMILY PRACTICE

BACKGROUND: Recently, faecal immunochemical tests (FITs) have been introduced for investigation of primary care patients with low-..

The diagnostic performance of CA125 for the detection of ovarian and non-ovarian cancer in primary care: A population-based cohort study

Garth Funston, Willie Hamilton, Gary Abel, Emma J Crosbie, Brian Rous, Fiona M Walter

Journal article  |  2020  |  PLOS MEDICINE

BACKGROUND: The serum biomarker cancer antigen 125 (CA125) is widely used as an investigation for possible ovarian cancer in sympt..